All Stories

  1. Elucidating the role of TPGS in felodipine/PVPVA amorphous solid dispersions during water uptake: dissipative particle dynamics simulations using quantum chemistry-based interaction parameters
  2. Enhancing the Physicochemical Properties of Trimethoprim through Complexation with Sulfathiazole
  3. Arginine–Asparagine Molecular Complex as a Natural Binder in Wet-granulated Tablets with High Hardness and Rapid Disintegration
  4. Dynamical Fragment Molecular Orbital Interaction Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase and Remdesivir
  5. Identifying Robust Parameters for Flowability Analysis of Pharmaceutical Powders Using the Shear Cell Method
  6. Film Coating of Small Molded Tablets for Pediatric Formulations with Rapid Disintegration and Bitterness-Masking Properties
  7. Granulation Methods and the Mechanisms for Improving Hardness of Loxoprofen Sodium Hydrate-Containing Tablets
  8. Evaluating Various Lactose Types as Solid Carriers for Improving Curcumin Solubility in Solid Self-Nanoemulsifying Drug Delivery Systems (S-SNEDDSs) for Oral Administration
  9. Characterization and Crystal Structural Analysis of Novel Carvedilol Adipate and Succinate Ethanol-Solvated Salts
  10. Fabrication and Characterization of Pectin Films Containing Solid Lipid Nanoparticles for Buccal Delivery of Fluconazole
  11. Crystal Polymorph Search in the NPT Ensemble via a Deposition/Sublimation Alchemical Path
  12. Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations
  13. The Development and Characterization of Novel Ionic Liquids Based on Mono- and Dicarboxylates with Meglumine for Drug Solubilizers and Skin Permeation Enhancers
  14. The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles
  15. Novel method for the accurate calculation of Drucker–Prager cap model parameters and reduction of experimental time and effort
  16. Characterization of co-amorphous carvedilol–maleic acid system prepared by solvent evaporation
  17. Physicochemical Properties and Transdermal Absorption of a Flurbiprofen and Lidocaine Complex in the Non-Crystalline Form
  18. Swelling and Salt Formation in Ibuprofen and Tranexamic Acid-Containing Tablets during High-Temperature Storage
  19. Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG)
  20. Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions
  21. Crystal Structures of Antiarrhythmic Drug Disopyramide and Its Salt with Phthalic Acid
  22. Crystal Structure of Novel Terephthalate Salt of Antiarrhythmic Drug Disopyramide
  23. Dose-Dependent Solubility–Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions
  24. Miscibility characterization of zein/methacrylic acid copolymer composite films and plasticization effects
  25. Cholesteryl-Conjugated Ribonuclease A Exhibits Enzyme Activity in Aqueous Solution and Resistance to Dimethyl Sulfoxide
  26. Synthesis and Characterization of Cholesteryl Conjugated Lysozyme (CHLysozyme)
  27. Application of void forming index (VFI): Detection of the effect of physical properties of dry powder inhaler formulations on powder cohesion
  28. Tablet Quality-Prediction Model Using Quality Material Attributes: Toward Flexible Switching Between Batch and Continuous Granulation
  29. Effect of Polymers and Storage Relative Humidity on Amorphous Rebamipide and Its Solid Dispersion Transformation: Multiple Spectra Chemometrics of Powder X-Ray Diffraction and Near-Infrared Spectroscopy
  30. Prediction of the Crystal Growth Mechanism of Aspirin Using Molecular Simulations
  31. Self‐Degradable Lipid‐Like Materials Based on “Hydrolysis accelerated by the intra‐Particle Enrichment of Reactant (HyPER)” for Messenger RNA Delivery
  32. Novel approach to evaluating granulation and segregation level considering the contribution of hydroxypropyl cellulose to the surface property change of granules
  33. Evaluation of the physical properties of dry surface-modified ibuprofen using a powder rheometer (FT4) and analysis of the influence of pharmaceutical additives on improvement of the powder flowability
  34. Degradation Pathway of a Taxane Derivative DS80100717 Drug Substance and Drug Product
  35. New approach to optimizing risk management of the sticking problem using scale-independent critical material attributes and the quantitative process parameter
  36. Preface of the Special Issue “Pharmaceutical Crystals”
  37. Crystal Structural Analysis of DL-Mandelate Salt of Carvedilol and Its Correlation with Physicochemical Properties
  38. Structural origin of physicochemical properties differences upon dehydration and polymorphic transformation of ciprofloxacin hydrochloride revealed by structure determination from powder X-ray diffraction data
  39. Formulation design and evaluation of a transdermal drug delivery system containing a novel eptazocine salt with the Eudragit® E adhesive
  40. Examples of Clinical Formulation Design at a University and Response to Clinical Need
  41. Importance of free water in controlling granule and tablet properties in a novel granulation method, green fluidized bed granulation (GFBG)
  42. A New Method for Classification of Salts and Cocrystals Using Solid-State UV Spectrophotometry
  43. Foreword
  44. Development of microparticles coated with poly-γ-glutamic acid to improve oral absorption of a poorly water-soluble drug
  45. Capturing a new hydrate polymorph of amodiaquine dihydrochloride dihydrateviaheterogeneous crystallisation
  46. Novel, Lean and Environment-friendly Granulation Method: Green Fluidized Bed Granulation (GFBG)
  47. Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine
  48. How Can the Researchers in University Be Involved with the Stream of Hospital Preparations from the Medical Needs to the Clinical Application?
  49. Solubility Improvement of Benexate through Salt Formation Using Artificial Sweetener
  50. Improvement of tabletability desloratadine
  51. Ethyl Haematommate fromStereocaulon graminosumSchaer.: Isolation and Crystal Structure
  52. Simultaneous Improvement of Epalrestat Photostability and Solubility via Cocrystallization: A Case Study
  53. Void forming index: A new parameter for detecting microstructural transformation caused by powder agglomeration
  54. Enhanced dissolution and skin permeation profiles of epalrestat with β-cyclodextrin derivatives using a cogrinding method
  55. A new solvate of epalerstat, a drug for diabetic neuropathy
  56. Epalrestat tetrahydrofuran monosolvate: crystal structure and phase transition
  57. Molecular Dynamics of Amorphous Sulfamethazine With Structurally Related Sulfonamide Impurities Evaluated Using Thermal Analysis
  58. Mechanisms for Improved Hygroscopicity of L-Arginine Valproate Revealed by X-Ray Single Crystal Structure Analysis
  59. Characterization of complexes between phenethylamine enantiomers and β-cyclodextrin derivatives by capillary electrophoresis-Determination of binding constants and complex mobilities
  60. Solubility improvement of epalrestat by layered structure formation via cocrystallization
  61. Effect of Magnesium Stearate Mono- and Dihydrate Dispersibilities on Physical Properties of Tablets
  62. The effect of structurally related impurities on crystallinity reduction of sulfamethazine by grinding
  63. Crystallographic Analysis of Phase Dissociation Related to Anomalous Solubility of Irsogladine Maleate
  64. Isostructural Multicomponent Gliclazide Crystals with Improved Solubility
  65. Crystal Structure Determination of Dimenhydrinate after More than 60 Years: Solving Salt–Cocrystal Ambiguity via Solid-State Characterizations and Solubility Study
  66. Drug–Drug Multicomponent Crystals as an Effective Technique to Overcome Weaknesses in Parent Drugs
  67. The effect of water activity on granule characteristics and tablet properties produced by moisture activated dry granulation (MADG)
  68. Tumor delivery of liposomal doxorubicin prepared with poly-L-glutamic acid as a drug-trapping agent
  69. General understanding on physical stability of pharmaceutical glasses
  70. Characterization and Quality Control of Pharmaceutical Cocrystals
  71. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes
  72. Triboelectrification of active pharmaceutical ingredients: week acids and their salts
  73. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA
  74. Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs II: Solvate and cocrystal
  75. Zoledronic acid enhances antitumor efficacy of liposomal doxorubicin
  76. Correlation between Glass-Forming Ability and Fragility of Pharmaceutical Compounds
  77. Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs I: Anhydrates and hydrate
  78. The importance of binder moisture content in Metformin HCL high-dose formulations prepared by moist aqueous granulation (MAG)
  79. Sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA could effectively deliver siRNA to the liver
  80. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages
  81. Effects of Formulation and Process Factors on the Crystal Structure of Freeze-Dried Myo-Inositol
  82. Studying the Morphology of Lyophilized Protein Solids Using X-ray Micro-CT: Effect of Post-freeze Annealing and Controlled Nucleation
  83. Relationship between Crystallization Tendencies during Cooling from Melt and Isothermal Storage: Toward a General Understanding of Physical Stability of Pharmaceutical Glasses
  84. Low-Density Microparticles with Petaloid Surface Structure for Pulmonary Drug Delivery
  85. Clarifying the mechanism of aggregation of particles in high-shear granulation based on their surface properties by using micro-spectroscopy
  86. In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex
  87. Optimization of Primary Drying Condition for Pharmaceutical Lyophilization Using a Novel Simulation Program with a Predictive Model for Dry Layer Resistance
  88. Importance of excipient wettability on tablet characteristics prepared by moisture activated dry granulation (MADG)
  89. Determination for dry layer resistance of sucrose under various primary drying conditions using a novel simulation program for designing pharmaceutical lyophilization cycle
  90. Polymorphic and pseudomorphic transformation behavior of acyclovir based on thermodynamics and crystallography
  91. Evaluation of physicochemical properties on the blending process of pharmaceutical granules with magnesium stearate by thermal effusivity sensor
  92. Evaluation of the crystalline and amorphous states of drug products by nanothermal analysis and Raman imaging
  93. Diffusivity of amorphous drug in solid dispersion
  94. Competition of Thermodynamic and Dynamic Factors During Formation of Multicomponent Particles via Spray Drying
  95. Practical Approach for Measuring Heat Capacity of Pharmaceutical Crystals/Glasses by Modulated-Temperature Differential Scanning Calorimetry
  96. Mechanism of Dehydration–Hydration Processes of Lisinopril Dihydrate Investigated by ab Initio Powder X-ray Diffraction Analysis
  97. Determination of Surface Free Energy and Contact Angle for Hydrolyzed Shellac
  98. Applying terahertz technology for nondestructive detection of crack initiation in a film-coated layer on a swelling tablet
  99. Cocrystallization and amorphization induced by drug–excipient interaction improves the physical properties of acyclovir
  100. Component Crystallization and Physical Collapse during Freeze-Drying of L-Arginine^|^#8211;Citric Acid Mixtures
  101. Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets
  102. Process analytical technology applied for end-point detection of pharmaceutical blending by combining two calibration-free methods: Simultaneously monitoring specific near-infrared peak intensity and moving block standard deviation
  103. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets
  104. Development of a Rapid Process Monitoring Method for Dry-Coated Tableting Process by Using Near-Infrared Spectroscopy
  105. Do Amorphous Troglitazones Prepared from Two Diastereomer-Pairs Have the Same Molecular Mobility and Crystallization Rate at the Surface?
  106. Molecular States of p-Dimethylaminobenzonitrile Coground with β-Cyclodextrin Investigated Using Solid-State Fluorescence Spectroscopy
  107. Study of the Pseudo-Crystalline Transformation from Form I to Form II of Thiamine Hydrochloride (Vitamin B1)
  108. Development of a method for nondestructive NIR transmittance spectroscopic analysis of acetaminophen and caffeine anhydrate in intact bilayer tablets
  109. Effects of Solute Miscibility on the Micro- and Macroscopic Structural Integrity of Freeze-Dried Solids
  110. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles
  111. Freeze-drying of proteins with glass-forming oligosaccharide-derived sugar alcohols
  112. Physicochemical Understanding of Polymorphism and Solid-State Dehydration/Rehydration Processes for the Pharmaceutical Material Acrinol, by Ab Initio Powder X-ray Diffraction Analysis and Other Techniques
  113. Prediction of the induction period of crystallization of naproxen in solid dispersion using differential scanning calorimetry
  114. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form
  115. Freeze-Drying of Proteins in Glass Solids Formed by Basic Amino Acids and Dicarboxylic Acids
  116. Solid States Fluorescence Study of p-Dimethylaminobenzonitrile by Co-grinding with Cyclodextrins
  117. Stabilization of Protein Structure in Freeze-Dried Amorphous Organic Acid Buffer Salts
  118. Evaluation of solid dispersions on a molecular level by the Raman mapping technique
  119. Development of a method for the determination of caffeine anhydrate in various designed intact tables by near-infrared spectroscopy: A comparison between reflectance and transmittance technique
  120. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol
  121. Applicability of DPI formulations for novel neurokinin receptor antagonist
  122. Effect of grinding on the dehydration behavior of nedocromil sodium hydrates
  123. Evaluation of dispersion state of the two racemic compounds of troglitazone in pharmaceutical granules using IR-to-THz imaging
  124. Application and Mechanism of Inhalation Profile Improvement of DPI Formulations by Mechanofusion with Magnesium Stearate
  125. Glass-State Amorphous Salt Solids Formed by Freeze-Drying of Amines and Hydroxy Carboxylic Acids: Effect of Hydrogen-Bonding and Electrostatic Interactions
  126. Effect of physical properties of troglitazone crystal on the molecular interaction with PVP during heating
  127. Application of microcalorimetry to the formulation study
  128. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry
  129. Mechanism of glass ampoule breakage prevention during the freeze-drying process of sodium thiopental lyophilization products on addition of sodium chloride
  130. Application of XRD-DSC system to the optimization of manufacturing process for the freeze-dried pharmaceuticals
  131. Solid-state 13C NMR study of indomethacin polymorphism
  132. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose
  133. Novel Approach to DPI Carrier Lactose with Mechanofusion Process with Additives and Evaluation by IGC
  134. Formulation design of a novel fast-disintegrating tablet
  135. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method
  136. Evaluation of the physical stability and local crystallization of amorphous terfenadine using XRD–DSC and micro-TA
  137. Investigation of optimal manufacturing process for freeze-dried formulations: Observation of frozen solutions by low temperature X-ray diffraction measurements
  138. Comparison of Molecular Mobility in the Glassy State Between Amorphous Indomethacin and Salicin Based on Spin-Lattice Relaxation Times
  139. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension
  140. Application of Eudragit RS to thermo-sensitive drug delivery systems
  141. Development of Fast Disintegrating Compressed Tablets Using Amino Acid as Disintegratation Accelerator: Evaluation of Wetting and Disintegration of Tablet on the Basis of Surface Free Energy
  142. Amorphous ultrafine particle preparation for improvement of bioavailability of insoluble drugs: grinding characteristics of fine grinding mills
  143. Change in the physicochemical properties of ursodeoxycholic acid by grinding
  144. Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives
  145. Physicochemical properties and surface free energy of ground talc
  146. Uniformity and physical states of troglitazone in solid dispersions determined by electron probe microanalysis and microthermal analysis
  147. Microscopic molecular mobility of amorphous AG-041R measured by solid-state 13C NMR
  148. Quantitative Determination of Amorphous Nicardipine Hydrochloride in Long Acting Formula (NIC-LA®) Using Light Anhydrous Silicic Acid
  149. Factors affecting the apparent solubility of ursodeoxycholic acid in the grinding process
  150. Solid-State Fluorescence Study of Naphthalene Adsorption on Porous Material
  151. Application of Eudragit RS to Thermo-Sensitive Drug Delivery Systems. I. Thermo-Sensitive Drug Release from Acetaminophen Matrix Tablets Consisting of Eudragit RS/PEG 400 Blend Polymers
  152. Estimation of Initial Dissolution Rate of Drug Substance by Thermal Analysis: Application for Carbamazepine Hydrate
  153. Characterization of Polymorphs of a Novel Quinolinone Derivative, TA-270 (4-Hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone).
  154. Interaction of Microcrystalline Cellulose and Water in Granules Prepared by a High-Shear Mixer.
  155. Molecular Properties of Propranolol Hydrochloride Prepared as Drug-Resin Complexes
  156. Molecular States of 2-Naphthoic Acid in Solid Dispersions with Porous Crystalline Cellulose, as Investigated by Fluorescence Spectroscopy
  157. Quantitative correlation between initial dissolution rate and heat of fusion of drug substance
  158. Near IR spectroscopy to quantify the silica content and difference between silicified microcrystalline cellulose and physical mixtures of microcrystalline cellulose and silica
  159. Specific complexation of ursodeoxycholic acid with guest compounds induced by co-grinding
  160. Effect of Water-Soluble Carriers on Dissolution Characteristics of Nifedipine Solid Dispersions
  161. Molecular State of Chlorpheniramine in Resinates.
  162. Physicochemical Properties of Ursodeoxycholic Acid Dispersed in Controlled Pore Glass
  163. Water sorption and near IR spectroscopy to study the differences between microcrystalline cellulose and silicified microcrystalline cellulose before and after wet granulation
  164. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying
  165. Fluorometric Studies of Pyrene Adsorption on Porous Crystalline Cellulose
  166. The use of near infra-red spectroscopy to detect changes in the form of amorphous and crystalline lactose
  167. Structural change and complexation of strictly linear amylose induced by sealed-heating with salicylic acid
  168. Effect of Guest Species on Inclusion Compound Formation of Deoxycholic Acid by Co-Grinding.
  169. Improved dissolution of ofloxacin via solid dispersion
  170. A 1:1 Deoxycholic Acid–Salicylic Acid Complex
  171. Enhanced Dissolution of Ursodeoxycholic Acid from the Solid Dispersion
  172. Time resolved fluorescent analysis for sealed heating of dimethyl-?-cyclodextrin and naphthalene system
  173. Freeze-drying of drug-additive binary systems. IV. Effects of saccharide addition on the crystallization of cefazolin sodium in frozen aqueous solution
  174. Thermal Behavior of Methyl p-hydroxybenzoate in Controlled-Pore Glass Solid Dispersion
  175. Dissolution studies in organic solvents for evaluating hydrogen-bond matrix of cellulose in the ground mixture
  176. Factors affecting the formation in the solid state of the metastable complex between naphthalene and dimethyl-?-cyclodextrin
  177. Peculiar Peak Shifts in the IR Spectrum of Benzoic Acid Crystals by Compression with Methylated Additives.
  178. Complex formation between naphthalene and dimethyl-β-cyclodextrin by heating in a sealed ampoule
  179. meta-Stable Complex Formation between 2,6-Di-O-methyl-,.BETA.-cyclodextrin and Naphthalene during Sealed-Heating Process.
  180. Physicochemical Properties of Amorphous Ursodeoxycholic Acid Obtained by Grinding.
  181. Acceleration of the addition reaction of succinic anhydride and p-nitroaniline in synthetic aluminium silicate
  182. Molecular States of Pyrene in the Ground Mixtures with Cyclodextrins Studied by Fluorescence Spectroscopy.
  183. Thermal behavior of ground mixtures of heptakis (2,6-di-O-methyl)-?-cyclodextrin and benzoic acid
  184. Polymorphism of Tegafur: Physico-chemical Properties of Four Polymorphs.
  185. Effect of Saccharide on the Decomposition of Cephalothin Sodium and Benzylpenicillin Potassium in Freeze-Dried Preparations.
  186. Solubility Parameter and Dissolution Behavior of Cefalexin Powders with Different Crystallinity.
  187. Diffusion and reaction of p-nitroaniline and succinic anhydride in controlled pore glass.
  188. New Methods for Preparing Cyclodextrin Inclusion Compounds. IV. Enhancement of Combining Molar Ratio by Using a Ground Mixture in Heptakis-(2,6-di-O-methyl)-.BETA.-cyclodextrin and Benzoic Acid System.
  189. Stability of aspirin in controlled pore glass solid dispersions.
  190. Freeze-drying of drug-additive binary systems III. Crystallization of α-cyclodextrin inclusion complex in freezing process
  191. Effect of grinding on dehydration of crystal water of theophylline.
  192. New methods for preparing cyclodextrin inclusion compounds. III. Preparation of heptakis-(2,6-di-O-methyl)-.BETA.-cyclodextrin-benzoic acid inclusion compound by sealed heating.
  193. Acceleration of the addition reaction of succinic anhydride and p-nitroaniline in controlled-pore glass solid dispersions.
  194. Freeze-drying of drug-additive binary systems. II. Relationship between decarboxylation behavior and molecular states of p-aminosalicylic acid.